Observational studyDrug design, development and therapy2016

Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability.

Francesca Bandinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.